A Randomized Trial of Incentives for Smoking Treatment in Medicaid Members.

Am J Prev Med

Center for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; Division of General Internal Medicine, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.

Published: December 2017

AI Article Synopsis

  • Low-income individuals, particularly Medicaid recipients, face challenges in smoking cessation, which the study aimed to address through monetary incentives.
  • The study involved a randomized trial comparing participants receiving incentives for smoking treatment calls and abstinence verification against a control group, with both groups being offered cessation resources.
  • Results indicated that those in the incentive group had higher smoking abstinence rates and were more engaged with smoking treatment services, demonstrating both the effectiveness and cost-effectiveness of using monetary rewards in smoking cessation efforts.

Article Abstract

Introduction: Low-income populations are especially likely to smoke and have difficulty quitting. This study evaluated a monetary incentive intended to increase smoking treatment engagement and abstinence among Medicaid recipients who smoke.

Study Design: Two-group randomized clinical trial of Incentive (n=948) and Control interventions (n=952) for smoking.

Setting/participants: Medicaid recipients recruited from primary care patients (n=920) and callers to the Wisconsin Tobacco Quit Line (n=980).

Intervention: Participants were offered five quitline cessation calls and were encouraged to obtain cessation medication (covered by Medicaid). All participants received payment for completing a baseline assessment and a 6-month smoking test. Only Incentive condition participants received compensation for taking counseling calls ($30 per call) and for biochemically verified abstinence at the 6-month visit ($40).

Main Outcome Measures: Seven-day point-prevalence smoking abstinence 6-months post study entry and cost/quit.

Results: Incentive condition participants had significantly higher biochemically determined 7-day point-prevalence smoking abstinence rates 6 months after study induction than did Controls (21.6% vs 13.8%, respectively, p<0.0001). A positive treatment effect of incentives was present across other abstinence indices, but the size of effects and levels of abstinence varied considerably across indices. Incentive condition participants were also significantly more likely than non-incentivized Control participants to accept Wisconsin Tobacco Quit Line treatment calls and their acceptance of calls mediated their attainment of higher abstinence rates at 6-month follow-up. The cost/quit/participant averaged $4,268.26 for the Control participants and $3,601.37 for the Incentive participants.

Conclusions: This study shows that fairly moderate levels of incentive payments for treatment engagement and abstinence (a total possible payment of $190) increased very low-income smokers' engagement and success in smoking cessation treatment.

Clinical Registration: This study is registered at www.clinicaltrials.gov: NCT02713594.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978743PMC
http://dx.doi.org/10.1016/j.amepre.2017.08.027DOI Listing

Publication Analysis

Top Keywords

smoking treatment
8
medicaid recipients
8
participants received
8
incentive condition
8
condition participants
8
point-prevalence smoking
8
smoking abstinence
8
smoking
5
randomized trial
4
trial incentives
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!